Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses
  • Ocular DB

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Mycobacterium leprae diversity and population dynamics in medieval Europe from novel ancient genomes.

Pfrengle S, Neukamm J, Guellil M, et al. BMC biology. 2021; 19 (1) : 220.
Download PDF
Publication

A History of Anti-leprosy Campaign in Sokoto Area of Northern Nigeria, 1919–1975

Abdullahi L. Springer International Publishing. The Political Economy of Colonialism and Nation-Building in Nigeria. 2021;
Publication

Effectiveness of self-care interventions for integrated morbidity management of skin neglected tropical diseases in Anambra State, Nigeria.

Eze C, Ekeke N, Alphonsus C, et al. BMC public health. 2021; 21 (1) : 1748.
Download PDF
Publication

Neglected tropical diseases: impact of COVID-19 and WHO’s response – 2021 update

World Health Organization . Weekly epidemiological record. 2021; 96 (38) : 461–476.
Download PDF
Publication

BCG re-vaccination in Malawi: 30-year follow-up of a large, randomised, double-blind, placebo-controlled trial.

Glynn J, Fielding K, Mzembe T, et al. The Lancet. Global health. 2021; 9 (10) : e1451-e1459.
Download PDF
Publication

Disability Level, Physical Activity Limitations, Self-esteem and Self-efficacy of Persons Living with Leprosy in Selected States in Nigeria

Umunnah JO, Mmadieke OC, Amaechi IA, et al. Sierra Leone Journal of Biomedical Research. 2021; 13 (1) : 1-8.
Download PDF
Publication

Evidence for hidden leprosy in a high leprosy-endemic setting, Eastern Ethiopia: The application of active case-finding and contact screening.

Urgesa K, Bobosha K, Seyoum B, et al. PLoS neglected tropical diseases. 2021; 15 (9) : e0009640.
Download PDF
Publication

Knowledge, Attitude and Practices of caregivers for patients with leprosy

Mohamed A, Ahmed E, Mohamed M. Egypts Presidential Specialized Council for Education and Scientific Research. Minia Scientific Nursing Journal. 2021; 009 (1) : 17-25.
Download PDF
Publication

Effect of Educational Program on Health Consequences of Patients with Leprosy

Ahmed AL, Mohamed NA. EE Publisher. Evidence-Based Nursing Research. 2021; 3 (3) : 12.
Publication

Putative pathogen-selected polymorphisms in the PKLR gene are associated with mycobacterial susceptibility in Brazilian and African populations.

Bezerra O, Alvarado-Arnez LE, Mabunda N, et al. PLoS neglected tropical diseases. 2021; 15 (8) : e0009434.
Download PDF

Pagination

  • Previous page ‹‹
  • Page 29
  • Next page ››
Subscribe to African Region (AFR)

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

© 2025 InfoNTD